Favorable course of pericardial angiosarcoma under paclitaxel followed by pazopanib treatment documented by cardiovascular magnetic resonance imaging

MeSH terms

• Adrenal Cortex Hormones / administration & dosage
• Adult
• Angiogenesis Inhibitors / administration & dosage
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Delayed Diagnosis
• Diagnostic Errors
• Doxorubicin / administration & dosage
• Drug Resistance, Neoplasm
• Etoposide / administration & dosage
• Heart Neoplasms / complications
• Heart Neoplasms / diagnosis
• Heart Neoplasms / drug therapy*
• Heart Neoplasms / pathology
• Hemangiosarcoma / complications
• Hemangiosarcoma / diagnosis
• Hemangiosarcoma / drug therapy*
• Hemangiosarcoma / pathology
• Humans
• Ifosfamide / administration & dosage
• Indazoles
• Lymphoma, Non-Hodgkin / diagnosis
• Magnetic Resonance Imaging
• Male
• Myocardium / pathology
• Paclitaxel / administration & dosage
• Pericardial Effusion / diagnosis
• Pericardial Effusion / etiology*
• Pericardial Effusion / pathology
• Pericardiocentesis
• Pericarditis / diagnosis
• Pericardium / pathology
• Protein Kinase Inhibitors / administration & dosage
• Pulmonary Embolism / etiology
• Pyrimidines / administration & dosage*
• Remission Induction
• Sulfonamides / administration & dosage*
• Vincristine / administration & dosage